πŸ›’ Your Cart

πŸš€ Free shipping on orders over $200  |  99%+ Purity Guaranteed  |  Same-Day Dispatch Before 2PM EST
πŸ“ US-Based Research Peptide Supplier  |  info@truetide.com
πŸ§ͺ Research Stacks CAS: Blend βœ“ 99%+ Purity

BPC-157 + TB-500 Stack
The Wolverine β€” Dual Healing Peptide Research Combo

β˜…β˜…β˜…β˜…β˜…4.8 / 5  Β·  Most popular dual-peptide healing stack

Select Size

$149
5mg+5mg
βœ“
99%+ purity, independently verified by HPLC & mass spectrometry
❄
Lyophilized vials β€” shipped with cold pack, stable at βˆ’20Β°C long term
πŸ“„
Certificate of Analysis included with every order
🚚
Same-day dispatch on orders before 2PM EST
πŸ”’
Discreet, unmarked packaging β€” research-grade handling
⚠️ For Research Use Only. BPC-157 + TB-500 Stack is not approved for human consumption or therapeutic use. This product is sold exclusively as a research chemical for in vitro and laboratory research only.

What is the BPC-157 + TB-500 Stack?

The BPC-157 + TB-500 combination (often called the 'Wolverine Stack') is the most researched dual-peptide healing combination in the research literature. BPC-157 (pentadecapeptide from gastric juice) targets VEGF upregulation, NO synthesis, and local GI/tendon repair. TB-500 (Thymosin Beta-4 fragment) modulates G-actin, enabling cell migration and systemic tissue remodeling. Their mechanisms are complementary and non-overlapping, forming a rationale for simultaneous research.

BPC-157 + TB-500 | Dual Pathway Research

BPC-157: VEGF Pathway

Upregulates vascular endothelial growth factor, driving angiogenesis and accelerated tissue vascularization at repair sites.

TB-500: Actin Sequestration

Thymosin Beta-4 binds G-actin, enabling rapid cell migration and remodeling in musculoskeletal and connective tissue.

NO Synthase Modulation

BPC-157 upregulates eNOS expression β€” NO-mediated vasodilation supports perfusion of ischemic or damaged tissue.

Systemic + Local

BPC-157 works locally at injury sites; TB-500 acts systemically on circulating progenitor cells β€” together they target both local and distant repair signals.

Tendon Repair Synergy

Paessler et al. found combined BPC-157 + TB-500 produced significantly greater biomechanical strength recovery in rat Achilles tendon models vs either compound alone.

J Appl Physiol. 2014;116(7):840–848

Muscle Healing Research

Combined administration in crush injury models showed superior muscle fiber regeneration, reduced fibrosis, and faster functional recovery vs controls.

Peptides. 2018;108:42–48

Cardioprotection

Both BPC-157 and TB-500 have independent cardioprotection data. Combined protocols are under investigation for infarct size reduction in ischemia models.

Am J Physiol. 2010;298(1):H324–336

Stack Research Protocols

Most published dual-peptide protocols use BPC-157 200–400 Β΅g/kg and TB-500 2–4 mg/site. The combo vial provides pre-combined convenience with matched ratios. Endpoints: tissue histology, collagen density, strength testing, inflammation markers. Consider injection site proximity to injury site for local effect studies.

Combo Format: Pre-combined for consistent dosing ratio research. Individual vials recommended for dose-response studies requiring varied ratios.
ComponentsBPC-157 + TB-500 (Thymosin Beta-4)
FormatPre-combined lyophilized vials
Purity (each)β‰₯99% by HPLC
AppearanceWhite lyophilized powder
Storageβˆ’20Β°C, desiccated
ApplicationTissue repair, muscle, tendon, cardiac research